Claims
- 1. An anti-stilbene antibody.
- 2. The antibody of claim 1 that is a monoclonal antibody.
- 3. The antibody of claim 1 designated 19G2, 20F2, 21C6, 22B9, 25F8, 25E2, 23E4, 23G3, 23D3, 23C2, 25C10, 24B6, 21E2, 16H10 and 9E11.
- 4. A hybridoma that produces the antibody of claim 3.
- 5. A method of detecting stilbene comprising the step of exposing stilbene to an anti-stilbene antibody and detecting an anti-stilbene/antibody-stilbene conjugate.
- 6. The method of claim 5 wherein detecting is accomplished by exciting the conjugate with light of a wavelength of from about 300 nm to about 350 nm and detecting emitted light having a wavelength of from about 380 nm to about 410 nm.
- 7. The method of claim 5 wherein the stilbene is attached to a target moiety.
- 8. The method of claim 7 wherein the target moiety is a polypeptide or polynucleotide.
- 9. The method of claim 7 wherein the target moiety is located in vivo.
- 10. A nucleoside that contains stilbene.
Government Interests
[0001] Funds used to support some of the studies reported herein were provided by the National Institutes of Health (GM4385, AI39089 and P01CA27489). The United States Government, therefore, has certain rights in this invention.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/US01/42160 |
9/13/2001 |
WO |
|